Partner Content Partner Content Official Agenda released for 8th annual Orphan Drugs and Rar... Agenda released for 8th Orphan Drugs and Rare Diseases
News ESMO26: Evidence for GSK's mo-rez builds in ovarian cancer New data from GSK's BEHOLD-1 study of B7-H4-targeted ADC mo-rez reinforce earlier results in platinum-resistant ovarian cancer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
